Cell therapies for neurological disease - From bench to clinic to bench

Expert Opinion on Biological Therapy

Volumn 5, Issue 3, 2005, Pages 289-291

  Harrower, Timothy ^a,b   Barker, Roger A ^a,b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Cell therapy; Huntington's disease; Parkinsons disease; Stem cells

Indexed keywords

ADOPTIVE IMMUNOTHERAPY; BIOLOGICAL THERAPY; CELL TRANSPLANTATION; CENTRAL NERVOUS SYSTEM; DOPAMINERGIC NERVE CELL; HUMAN; NERVE CELL; NERVE REGENERATION; NEUROLOGIC DISEASE; PARKINSON DISEASE; REVIEW; STEM CELL; SUBSTITUTION THERAPY;

ANIMALS; BIOMEDICAL RESEARCH; HUMANS; NERVOUS SYSTEM DISEASES; STEM CELL TRANSPLANTATION;

EID: 17144417137     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712598.5.3.289     Document Type: Review

References (14)

1. ERIKSSON PS, PERFILIEVA E, BJORK-ERIKSSON T et al.: Neurogenesis in the adult human hippocampus. Nat. Med. (1998) 4(11):1313-1317.
2. FREED CR, GREENE PE, BREEZE RE et al.: Transplantation of embryonic dopamine neurons for severe Parkinsons disease. N. Engl. J. Med. (2001) 344(10):710-719.
3. OLANOW CW, GOETZ CG, KORDOWER JH et al.: A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinsons disease. Ann. Neurol. (2003) 54(3):403-414.
4. ROSSER AE, BARKER RA, HARROWER T et al.: Unilateral transplantation of human primary fetal tissue in four patients with Huntington's disease: NEST-UK safety report ISRCTN no 36485475. J. Neurol. Neurosurg. Psychiatry (2002) 73(6):678-685.
5. BACHOUD-LEVI A, BOURDET C, BRUGIERES P et al.: Safety and tolerability assessment of intrastriatal neural allografts in five patients with Huntington's disease. Exp. Neurol. (2000) 161(1):194-202.
6. BACHOUD-LEVI AC, REMY P, NGUYEN JP et al.: Motor and cognitive improvements in patients with Huntington's disease after neural transplantation. Lancet (2000) 356(9246):1975-1979.
7. HARROWER TP, BARKER RA: The emerging technologies of neural xenografting and stem cell transplantation for treating neurodegenerative disorders. Drugs Today (Barc.) (2004) 40(2):171-189.
8. BARKER RA, JAIN M, ARMSTRONG RJ, CALDWELL MA: Stem cells and neurological disease. J. Neurol. Neurosurg. Psychiatry (2003) 74(5):553-557.
9. KIM JH, AUERBACH JM, RODRIGUEZ-GOMEZ JA et al.: Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinsons disease. Nature (2002) 418(6893):50-56.
10. PLUCHINO S, QUATTRINI A, BRAMBILLA E et al.: Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis. Nature (2003) 422(6933):688-694.
11. SUGAYA K, BRANNEN CL: Stem cell strategies for neuroreplacement therapy in Alzheimer's disease. Med. Hypotheses (2001) 57(6):697-700.
12. RIESS P, ZHANG C, SAATMAN KE et al.: Transplanted neural stem cells survive, differentiate, and improve neurological motor function after experimental traumatic brain injury. Neurosurgery (2002) 51(4):1043-1052.
13. ARMSTRONG RJ, BARKER RA: Neurodegeneration: a failure of neuroregeneration? Lancet (2001) 358(9288):1174-1176.
14. GILL SS, PATEL NK, HOTTON GR et al.: Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson's disease. Nat. Med. (2003) 9(5):589-595.